Does FOSAPREPITANT DIMEGLUMINE Cause Maternal exposure timing unspecified? 15 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 15 reports of Maternal exposure timing unspecified have been filed in association with FOSAPREPITANT DIMEGLUMINE (Fosaprepitant). This represents 1.7% of all adverse event reports for FOSAPREPITANT DIMEGLUMINE.
15
Reports of Maternal exposure timing unspecified with FOSAPREPITANT DIMEGLUMINE
1.7%
of all FOSAPREPITANT DIMEGLUMINE reports
14
Deaths
14
Hospitalizations
How Dangerous Is Maternal exposure timing unspecified From FOSAPREPITANT DIMEGLUMINE?
Of the 15 reports, 14 (93.3%) resulted in death, 14 (93.3%) required hospitalization, and 15 (100.0%) were considered life-threatening.
Is Maternal exposure timing unspecified Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for FOSAPREPITANT DIMEGLUMINE. However, 15 reports have been filed with the FAERS database.
What Other Side Effects Does FOSAPREPITANT DIMEGLUMINE Cause?
Dyspnoea (142)
Pyrexia (136)
Nausea (130)
Infusion related reaction (83)
Diarrhoea (80)
Vomiting (71)
Rash (66)
Hypersensitivity (65)
Stomatitis (64)
Decreased appetite (62)
What Other Drugs Cause Maternal exposure timing unspecified?
RITUXIMAB (402)
METHOTREXATE (350)
ADALIMUMAB (343)
DICLOFENAC (331)
TOCILIZUMAB (327)
HYDROXYCHLOROQUINE (309)
FOLIC ACID (304)
INFLIXIMAB (303)
LEFLUNOMIDE (302)
SECUKINUMAB (301)
Which FOSAPREPITANT DIMEGLUMINE Alternatives Have Lower Maternal exposure timing unspecified Risk?
FOSAPREPITANT DIMEGLUMINE vs FOSCARBIDOPA\FOSLEVODOPA
FOSAPREPITANT DIMEGLUMINE vs FOSCARNET
FOSAPREPITANT DIMEGLUMINE vs FOSFOMYCIN
FOSAPREPITANT DIMEGLUMINE vs FOSFOMYCIN TROMETHAMINE
FOSAPREPITANT DIMEGLUMINE vs FOSINOPRIL